Leveraged loans news-in-brief, January 17, 2014

Patheon does transatlantic — Wendel signs revolver — Elis expects strong backing — Mergermarket gets credit rating — Sophos adds euros

  • By Olivier Holmey
  • 17 Jan 2014

Patheon markets transatlantic cov-lite for DSM merger

Toronto-listed pharmaceuticals firm Patheon is in the market for a $1.15bn-equivalent seven year covenant-lite loan package.

The transatlantic deal will back the merger of Patheon with DSM Pharmaceutical Products, Royal DSM’s pharmaceutical business, as announced in November.

Private equity firm ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 6,415 22 12.84
2 Citi 5,781 17 11.57
3 BNP Paribas 3,530 14 7.06
4 Credit Suisse 2,783 8 5.57
5 Rabobank 2,633 4 5.27

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 98,446.48 276 13.35%
2 Bank of America Merrill Lynch 90,174.33 262 12.23%
3 Wells Fargo Securities 70,282.48 216 9.53%
4 JPMorgan 51,967.93 167 7.05%
5 Credit Suisse 41,447.11 125 5.62%